Desde 500€ puedes invertir en Biocross a través de Blockchain
the life expectancy and quality of life of individuals with neurodegenerative diseases
through the design of innovative diagnostic systems.
and non-invasive diagnostic tools that can be used
at any stage of the disease.
Early diagnosis
Reliable
Non-invasive
Our goal
To provide neurologists with an integrated diagnostic solution that can be applied to any stage of the disease, including the earliest, asymptomatic phase.
Benefits
- Reduced cost of AD risk-assessment and diagnosis.
- More widespread testing thanks to simpler, more readily available diagnostic methods.
- Improved diagnosis, through earlier detection and differentiation of distinct dementia types.
- Simplified diagnosis through leveraging of existing laboratory equipment.
- Improved patient experience and safety.
The e4Risk® is a non-genetic, cost-effective, and highly reliable method to detect the presence of the ApoE4 protein in human blood plasma using high-throughput chemical analysis.
A Valladolid -based company develops a test for the diagnosis of Alzheimer’s disease in blood samples.
The company recently completed a multicenter exploratory study in which seven Spanish hospitals participated, to identify markers of the disease. The study involved 306 patients.
Biocross becomes the main sponsor of Positive SimRacing
Biocross is a young Spanish biotechnology company based in the bioincubator in Boecillo Technology Park, near the headquarters of Positive SimRacing in Valladolid (Spain).
Alzheimer’s in the spotlight
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid).
If you have any questions or comments, we will be pleased to attend you
Avda. Francisco Vallés, 8
47151 Boecillo (Valladolid) - Spain
+34 983 54 98 96